Daniel Devine & Co »

SPDR S&P Biotech shares owned by Daniel Devine & Co

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Daniel Devine & Co from 13F filings

Historical chart of Daniel Devine & Co investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Daniel Devine & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Daniel Devine & Co

Quarter filed Position value Share count Share price at filing
2018-06-30 $704k 7.4k 95.14
2018-03-31 $553k 6.3k 87.78

More positions owned by Daniel Devine & Co

Spdr S&p 500 Etf (SPY)
PowerShares QQQ Trust, Series 1
SPDR S&P MidCap 400 ETF (MDY)
Apple (AAPL)
iShares NASDAQ Biotechnology Index (IBB)
Johnson & Johnson (JNJ)
Berkshire Hathaway Inc. Class B
Visa (V)
Abbvie (ABBV)
Chevron Corporation (CVX)
iShares MSCI Emerging Markets Indx (EEM)
UnitedHealth (UNH)
Honeywell International (HON)
Pfizer (PFE)
Costco Wholesale Corporation (COST)

View all positions for Daniel Devine & Co

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities

View all funds holding SPDR S&P Biotech